Viewing nowPrilene Capsule 150mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

MFDS item code 201603602 · Approved 2016.06.20 · Insurance code 649807170
Relief of peripheral and central neuropathic pain, adjunctive treatment for partial seizures in epilepsy, improvement of fibromyalgia.
This medication is used to treat peripheral and central neuropathic pain in adults and is used as an adjunctive treatment for partial seizures in patients with epilepsy. It is also an effective drug for the treatment of fibromyalgia. In other words, it helps improve various pain and seizure symptoms related to the nervous system.
This medication is administered orally, divided into two doses daily, irrespective of food. 1. Neuropathic pain - Peripheral neuropathic pain: An initial dose of 150 mg may be administered daily, and after 3 to 7 days, it may be increased to 300 mg daily, with a maximum of 600 mg if needed, at 7-day intervals. - Central neuropathic pain: Starting with 150 mg daily, 1
Safety and efficacy data for children under 12 years and adolescents aged 12 to 17 years are insufficient, so use is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so patients should inform healthcare professionals immediately if they experience depression or mood changes during treatment. Patients with allergies to any component of this medication or specific genetic issues such as lactose intolerance should not take it. Diabetic patients should note that weight gain may necessitate adjustments to their blood sugar control medications. If serious allergic reactions, such as angioedema, occur, medication should be stopped immediately, and medical advice should be sought. Elderly patients should be cautioned that dizziness or drowsiness may increase when taking this medication, and precautions should be taken to reduce the risk of falls. Some patients may experience blurred vision or changes in vision; if these symptoms occur, the medication should be stopped or healthcare professionals should be consulted. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it is recommended to gradually taper off under the guidance of a healthcare professional. Patients with a history of substance abuse should exercise special caution due to the potential for abuse of this medication, and should report any unusual behaviors immediately. Patients with impaired renal function may require dosage adjustments for this medication. Patients with heart disease should be aware that cardiovascular issues, such as congestive heart failure, may arise when taking this medication. When taking this medication with other drugs that have central nervous system depressant effects or opioid analgesics, the risk of respiratory depression may increase; therefore, consultation with healthcare professionals is essential. During early pregnancy, it may pose risks to the fetus; therefore, women who are pregnant or planning to become pregnant should consult with a physician before taking it and must use effective contraception while on this medication. Breastfeeding women should consult with healthcare professionals about the possibility of this medication passing into breast milk and potentially affecting the infant, considering discontinuation of breastfeeding or the medication. Dizziness and drowsiness may occur while taking this medication, so it is advisable to avoid dangerous activities such as driving or operating machinery until one is aware of how the medication affects them. In overdose situations, confusion, drowsiness, depression, and seizures may occur, necessitating immediate medical attention.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain room temperature between 15 to 30 degrees Celsius.
White or pale yellow powder contained in a white hard capsule with a white upper and lower part.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.